https://pharminent.com/genentech-licenses-hanmis-muscle-sparing-obesity-drug-in-deal-worth-up-to-2-3-billion/ 2026-08-24T21:12:09Z Pharminent en Genentech Licenses Hanmi's Muscle-Sparing Obesity Drug in Deal Worth Up to $2.3 Billion 2026-08-24T20:39:44Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-24-2026/ 2026-08-24T20:33:51Z Pharminent en Strategic News Watch • August 24, 2026 2026-08-24T20:33:48Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-august-21-2026/ 2026-08-23T14:21:38Z Pharminent en GLP-1 Competitive Market Digest • Weekly • August 21, 2026 2026-08-23T14:21:36Z Blog